September 14, 2021

N4 Pharma pleased with initial in vitro results from new SARS-COV-2 plasmid

N4 Pharma Plc (LON:N4P), the specialist pharmaceutical company developing Nuvec®, a novel delivery system for cancer treatments and vaccines, has provided a further update on its current in vivo work..

Search

Funds

September 14, 2021

Search

Funds

September 14, 2021

FTSE 100

Funds